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Abstract
Recent years have seen various reviews on the lack of access to radiotherapy often based on geographic regions of the world such as Africa, Asia Paciﬁc, Europe,
Latin America and North America. Countries are often deﬁned by their national income per capita levels based on World Bank deﬁnitions of high income, upper
middle income, lower middle income and low income. Within the world regions, there are signiﬁcant variations in gross national income (GNI) per capita
among the different countries, and even within similar income levels, large variations exist. This report presents the actual status of radiotherapy and analyses
the current needs and costs to provide full access in the different regions of the world. Actual coverage of the needs ranges from 34% in Africa to over 92% in
Europe to about double the needs in North America. In line with this, proportional additional investments and operational costs are as high as more than 200%
in Africa to almost none in North America. Two world regions face substantial challenges: Africa, based on the important demands to build new capacity and
subsequently to maintain operational capability; and Asia Paciﬁc, due to its high population density, translating into large absolute needs in radiotherapy
treatments and resources, and hence in associated costs. With the data highlighting a large variability of GNI/capita even within similar income levels in the
various world regions, it is expected that additional investment in resources and costs may be more dependent on income level of the country than on the GNI
group or the geographic region of the world.
 2016 The Royal College of Radiologists. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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The list and income classiﬁcation of countries was taken
from the World Bank, Country and Lending Groups, 2017
ﬁscal year (http://data.worldbank.org/about/country-and-
lending-groups). Data on population, number of cancer
cases per country and per region, and number of cancer
cases for each cancer site were obtained from GLOBOCAN
2012 (http://globocan.iarc.fr; http://globocan.iarc.fr/Pages/
fact_sheets_population.aspx). Data on availability of radio-
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at http://dirac.iaea.org. We used an internally produced
Excel sheet with data from December 2015.Introduction
In recent years, a large body of evidence has emerged on
the availability and needs of radiotherapy. In contrast to
common expectations, considerable gaps in access to
radiotherapy have not only been observed in low- and
middle-income countries (LMICs) [1e6], but also in most
European countries. Although the latter region is typically
considered a high-income region where resources and ac-
cess consequently should be optimal, important variations
have been observed in available human and capital re-
sources, translating into variable gaps in radiotherapy pro-
vision [7e12]. The most comprehensive, worldwide,d. This is an open access article under the CC BY-NC-ND license (http://
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International Cancer Control’s Global Task Force on Radio-
therapy for Cancer Control (GTFRCC) [2].
These reports have used different sources for input data
collection and computed the gap in access to radiotherapy
using different methodological approaches. The Health
Economics in Radiation Oncology (HERO) project from the
European Society for Radiotherapy and Oncology used data
from their own survey, obtained and validated in close
collaborationwith the national societies for radiotherapy in
Europe [7e9] and reported the gap between the evidence-
based optimal and the actually delivered radiotherapy
treatments across Europe [11]. It was concluded that access
to radiotherapy remains limited in many European coun-
tries, even some of the more afﬂuent. Most other studies
relied on data input from the Directory of Radiotherapy
Centres (DIRAC), the International Atomic Energy Agency’s
(IAEA) voluntary global registry on radiotherapy resources
[2,10,12,13]. In most instances, the actual needs were esti-
mated as the additional number of capital (mostly linear
accelerators; linacs) and/or human resources required to
allow full coverage of radiotherapy in a subset of countries
or certain regions, based on generally accepted deﬁnitions
on resource throughput and using various assumptions on
other parameters such as operating hours [10,12,14,15]. The
GTFRCC report used a more reﬁned time-driven activity-
based costing (TD-ABC) approach that did not only allow
computing investment and operational costs, but also
provided insight into resource utilisation and shortfalls in
coverage [2]. Although the number of additional machines
needed varies between these reports, the overall conclu-
sion is that around 50% of cases requiring radiotherapy in
LMICs do not have access to treatment, and the ﬁgure of
unavailable need rises to 90% in low-income countries
(LICs).
Accurate data on the cost of radiotherapy remain scarce
in today’s literature. A recent systematic review of the
available radiotherapy costing literature observed that only
a minority of costing studies used conventional costing
methodologies, which, together with the large heteroge-
neity in scope of the analyses and in inputs used and out-
puts reported, did not allow the presentation of a consistent
picture of radiotherapy costs [16]. Moreover, only one of the
studies in the review provided cost data for a range of
different countries [17]. To date, the GTFRCC is the only
report that has estimated the investment and operational
costs for radiotherapy across the globe. To provide input to
an investment model that would allow closing the gap in
radiotherapy provision by 2035, the report focused on in-
cremental costs to cover additional resources needed over
the next 20 years [2].
Here we present the current radiotherapy needs in
LMICs, together with the investment and operational costs
for optimal coverage to date. Moreover, being aware that
LMICs are spread around different regions in the world, we
analyse the needs and costs on the proportion of low-,
lower middle- (L-MIC), upper middle- (U-MIC) and high-
income (HIC) countries in the different world regions.Please cite this article in press as: Zubizarreta E, et al., Analysis of Global R
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Countries were classiﬁed according to the deﬁnitions of
the World Bank for 2017 [18]. For the current 2017 ﬁscal
year, low-income economies are deﬁned as those with a
gross national income (GNI) per capita, calculated using the
World Bank Atlas method, of US$1025 or less in 2015; lower
middle-income economies are those with a GNI per capita
between US$1026 and US$4035; upper middle-income
economies are those with a GNI per capita between
US$4036 and US$12 475; high-income economies are those
with a GNI per capita of US$12 476 or more. TheWorld Bank
includes 217 economies, of which 79 are categorised as HIC,
55 as U-MIC, 52 as L-MIC and 31 as LIC. Forty-three small
countries in this list are not reported by GLOBOCAN or
DIRAC, hence they were not included in the analysis. The
ﬁnal number of economies included was 174, divided into
53 HIC, 46 U-MIC, 45 L-MIC and 30 LIC.
The actual analysis was carried out by geographic re-
gions, based on the deﬁnition of regions used by the IAEA
Technical Cooperation Department. Europe includes the
post-Soviet countries in Central Asia and contains 29 HICs,
14 U-MICs and six L-MICs. North America refers to Canada
and the USA, and Asia Paciﬁc includes the rest of Asia and
Oceania, with 15 HICs, eight U-MICs, 18 L-MICs and three
LICs. Latin America is formed by seven HICs, 15 U-MICs, ﬁve
L-MICs and one LIC and Africa by nine U-MICs, 16 L-MICs
and 26 LICs. Interestingly, the population of Asia Paciﬁc is
41% bigger than all four other regions combined.Courses, Resources and Costs
The actual situation, based on today’s available re-
sources, was evaluated and compared with the optimal
situation, where resources would match the needs to treat
all patients with an indication for radiotherapy. Resources
in the latter situation are further referred to as ‘total re-
sources’ and the associated costs as ‘total costs’.
Two previously published models were used. The total
number of radiotherapy courses needed to treat all patients
with an indication for radiotherapy to date was calculated
using the evidence-based estimation method (EBEST) from
the Collaboration for Cancer Outcomes Research and Eval-
uation (CCORE) [19e21]. The TD-ABC model developed for
the GTFRCC [2], based on former IAEA activity-based costing
and stafﬁng models [22,23] was used to compute the total
resources needed to deliver these courses as well as to
calculate the costs, actual and total investment and opera-
tional costs, and costs per course.
The main assumptions and input variables, which are
largely in line with those used for the GTFRCC report [2], are
described below.
Courses
Based on data from GLOBOCAN 2012 [24], the number of
current radiotherapy indications, for external beamadiotherapy Needs and Costs by Geographic Region and Income Level,
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therapy, was calculated for each country with the latest
version of the CCORE-EBEST model [19,20,21].
The average number of external beam radiotherapy
fractions per radiotherapy case was 19.4 for all scenarios. All
patients were assumed to be treated with three-
dimensional conformal radiation therapy (3DCRT) in
LMICs. In HICs, 50% of the patients were assigned to 3DCRT,
50% to intensity-modulated radiotherapy and half of the
total number were assumed to have daily image-guided
radiotherapy. Retreatment was not considered, primarily
because it has been described to have a very small (̴ 1e4%)
impact on the results [2,25].
Brachytherapy was not assumed to be essential for other
tumour sites. The proportion of radiotherapy cases
requiring brachytherapy was 1.5% for HICs, 4% for U-MICs,
10% for L-MICs and 14% for LICs, generally ranging between
one and ﬁve fractions [26].
Resources
The number of radiotherapy departments and mega-
voltage (MV) machines, i.e. linacs and cobalt machines, was
taken from IAEA-DIRAC, as of December 2015 [13]. An
average of two MV machines per department was used for
the calculations in line with available data showing that the
actual average number of MV machines per department is
less than two [10]. Radiotherapy departments were
assumed to operate 12 h per day, 5 days per week and 50
weeks per year. As in the report of the GTFRCC, all
equipment-related quality assurance and preventive
maintenance activities were assumed to be undertaken
outside clinical hours [2].
In all scenarios, half of the linacs were assumed to have a
single photon energy. For current capacity, 75% were esti-
mated to be equipped with multileaf collimators and elec-
tronic portal imaging devices in HICs, 10% in U-MICs and
none in L-MICs and LICs. On-board imaging cone beam
computed tomography was assumed to be present on 25%
of the linacs in HICs only. For total capacity, all linacs in all
scenarios were upgraded to have multileaf collimators and
electronic portal imaging devices, and 50% of linacs in HICs
were upgraded with on-board imaging cone beam
computed tomography. No cobalt machines were added to
generate full capacity, but existing ones were maintained.
Data on ancillary radiotherapy equipment are non-
existent at the global level. Hence, in addition to the as-
sumptions on the linac-related image-guidance equipment,
each department was assumed to have one computed to-
mography simulator, a 3DCRT-capable radiation treatment
planning system, an oncology information management
system and appropriate dosimetry, quality assurance and
radiation protection equipment. This, as well as facility
layout and size being based on IAEA guidance documents,
conformed to the approach used in the GTFRCC [2].
Similarly, as there are no reliable world-wide data on the
availability of radiotherapy professionals, stafﬁng levels
were assumed to be adequate for handling the equipment
in both the actual and optimal situations, i.e. actual and totalPlease cite this article in press as: Zubizarreta E, et al., Analysis of Global Ra
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ment and treatments. The same approach was used by the
GTFRCC [2].
Costs
Salaries were based on surveys and global databases, and
as with the training, equipment and construction costs, they
were the same as those used by the GTFRCC [2].Different Regions Across the Globe: a
Highly Variable Picture
Figure 1 gives an overview of the GNI/capita in the ﬁve
world regions with each dot representing a country. For
each region, the blue dots represent theweighted averagee
based on the size of the countries’ populations in that re-
gion and income level. Although, according to the World
Bank, GNI regions are deﬁned by upper and/or lower GNI/
capita thresholds, it is clear that within the different
geographic regions, the actual income of the countries
within a speciﬁc income level varies a lot. Also, across re-
gions, theweighted average GNI/capita is not consistent. For
instance, although the average for HICs is similar in Europe
and Asia Paciﬁc, these are lower than the average in North
America and much higher than that for Latin America.
Similarly, in L-MICs, the Asia Paciﬁc average is clearly lower
than that for Europe, the latter being more in line with Latin
America and Africa.
Table 1 provides a detailed overview of the main ﬁndings
of the calculations carried out in this study, organised by the
different world regions. It shows the currently available
resources and the related costs e annual operational costs
and average cost per course e calculated for the status of
equipment to date. In addition, it presents an estimate of
the total number of courses needed to generate full access,
with the related projection of total resources needed.
Finally, it gives the total investment costs, based on capital
investment and training, needed to optimise access, as well
as the operational costs and cost per course projected for
this optimal situation. As can be observed, the coverage in
Africa is only about one third of the optimal, whereas
coverage nearly reaches two-thirds in Asia Paciﬁc and in
Europe and Latin America it hovers around 90%. Conversely,
based on our computations, North America seems to be
signiﬁcantly over-resourced. It can only be hypothesised
that this ﬁnding is due to a combined effect of a real excess
in available equipment together with different operational
models (less working hours per day, longer treatment time
slots e all or not related to more complex treatment stra-
tegies) used in todays’ US radiotherapy practice.
Figure 2 provides further insight into the investments
needed to close the gap in the different world regions,
compared with the investments by income group. It is clear
that at the regional level, overall challenges are biggest for
Asia Paciﬁc, predominantly in the U-MICs and L-MICs. Africa
has important needs in L-MICs and LICs. Both Europe and
North America still have additional needs in the HIC group,diotherapy Needs and Costs by Geographic Region and Income Level,
Fig 1. Gross national income (GNI)/capita in different regions of the world together with country income groups. Each dot represents a country
with the colours illustrating the income group of that country. The averages of a particular income group in a particular region are illustrated by
the dark blue dots. AF, Africa; AP, Asia Paciﬁc; EU, Europe; LA, Latin America; NA, North America; HIC, high-income country; U-MIC, upper
middle-income country; L-MIC, lower middle-income country; LIC, low-income country.
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training in Europe, and is mainly based on investment in
human resources, especially physicists, in North America.
Looking at the companion part of the ﬁgure with distribu-
tion by income groups, it is again the total investment needs
of Asia Paciﬁc that dominate the picture, in U-MICS and L-
MICs.
Although in absolute numbers the needs of Asia Paciﬁc
are clearly the most impressive, in relative numbers
(Figure 3), it is clear that Africa is also facing a major, be it
completely different, challenge: it has to build up a large
amount of capacity almost from scratch, yielding additional
needs and costs in the order of 200%. In relative terms,
additional needs of Asia Paciﬁc only hover between 40 and
70%. Based on the parallel expansion of courses and re-
sources in the model, the incremental cost per course is
limited in all regions of theworld, with even a slightly lower
cost observed in Asia Paciﬁc, due to the increased propor-
tion of lower cost per course from Asia Paciﬁc U-MICs and L-
MICs in the ﬁnal cost per course.Please cite this article in press as: Zubizarreta E, et al., Analysis of Global R
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Variability of Available Resources Within Geographic
Regions
It is clear that there is a huge worldwide variation in the
availability of radiation therapy [2]. Although, broadly
speaking, this variation tracks with regional income levels,
the data in this paper show plainly that there are large
variations in GNI/capita for different countries within each
of the ‘geographic’ regions, indicating that these regions are
by nomeans homogeneous in that respect. The exception to
this is North America but even here this is not truly correct
as, for the regional deﬁnition, North America is deﬁned to
be Canada and the USA and does not include Mexico, which
is in the Latin American region. It should be noted that even
within Canada and the USA there are also large variations in
income levels e the variation within the USA being a factor
of two or ﬁve depending on whether the District of
Columbia is included or not [27] and in Canada the ratio isadiotherapy Needs and Costs by Geographic Region and Income Level,
Fig 2. Additional investment needed to provide full access to radiotherapy by geographic region and by income group. AF, Africa; AP, Asia Paciﬁc;
EU, Europe; LA, Latin America; NA, North America; HIC, high-income country; U-MIC, upper middle-income country; L-MIC, lower middle-
income country; LIC, low-income country.
Table 1
Summary of actual status and total needs to provide full access to radiotherapy in the different regions of the world
Africa Asia Paciﬁc Europe Latin America North America
Population and courses
Population (million) 1070 4108 893 601 350
Actual radiotherapy courses 148 600 1 914 454 1 712 000 503 000 934 746
Total radiotherapy courses 437 624 3 277 387 1 884 893 573 385 934 746
Resources
Actual radiotherapy centres 140 2585 1431 620 2787
Total radiotherapy centres needed
for full access (working 12 h/day)
407 3503 1449 624 1200
Actual megavoltage machines 277 3894 3751 968 4243
Percentage cobalt machines 30.0% 19.8% 16.0% 30.1% 3.6%
Total megavoltage machines needed
for full access (working 12 h/day)
813 6406 4098 1106 2175
Actual coverage of the needs 34% 61% 92% 88% 195%
Costs
Capital þ training costs needed to bring to
full access (million US$)
2118 10 497 2573 918 1558
Actual operational costs/year (million US$) 182 4638 5868 975 6151
Total operational costs/year (million US$),
assuming full access
571 6968 6573 1192 6588
Actual cost per radiotherapy course (US$) 1226 2423 3428 1939 6581
Total cost per radiotherapy course (US$),
assuming full access
1306 2126 3487 2079 7048
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Fig 3. Additional courses, resources and costs (percentage extra needs). AF, Africa; AP, Asia Paciﬁc; EU, Europe; LA, Latin America; NA, North
America.
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[28]. Even larger spreads can be seen in the Asia Paciﬁc
region, where variations for some of the large countries
range between US$60 070 for Australia and US$1590 for
India [29].
Whereas in Asia Paciﬁc and Latin America the four
different income levels are represented, this is not the case
for Africa, where there are no HICs, or for Europe, where
LICs are non-existent. The exceptional situation of North
America only constituting HICs has already been discussed.
Overall, the weighted average GNI/capita in Africa is three
times lower than in Asia Paciﬁc, ﬁve times lower than in
Latin America and represents only 8.1% and 3.8%, respec-
tively, of the GNI/capita in Europe and North America. On
top of this, even if the GNI/capita has been clearly deﬁned
by income level, it should be noted that the distribution of
wealth among the different countries of a geographic region
may be quite inhomogeneous, with variable average GNI/
capita as a result. As an example, the weighted average GNI/
capita in HICs of Latin America is less than 40% of that in
Asia Paciﬁc and Europe and 27% of that in North America.
This large worldwide variability in wealth translates into
variations in available resources for radiotherapy, as has
been highlighted in the report of the GTFRCC [2]. This kind
of variability has also been observed before in various re-
gions of the world. In Europe, for example, the HERO project
described the large variation in available staff [7] and
equipment [8] per million inhabitants. Moreover, activity
levels, such as annual courses per machine or personnel
type, were found to be inversely related to the country’s
wealth and a corresponding clustering of resources ac-
cording to GNI/capita was found [9]. Recent reports fromPlease cite this article in press as: Zubizarreta E, et al., Analysis of Global R
Clinical Oncology (2016), http://dx.doi.org/10.1016/j.clon.2016.11.011the IAEA have indicated the actual status of radiotherapy
resources in Africa and more globally in LMICs. Here too,
large inter-country variations were observed [4,12].
Where do we Need Additional Resources and What are the
Foreseeable Investments?
The additional resources projected in the calculations e
in the order of magnitude of 200% e show that relatively
Africa has the greatest needs, with a present capacity of 34%
of their optimal needs (Table 1, Figure 3). Europe and Latin
America are relatively close (within 12%) in their needs,
whereas North America has almost twice the capability
compared with what they actually need based on the
calculation methodology of this report. Overall, there is a
reasonably good alignment between the additional courses
needed per region and the capital resources, especially the
number of linacs. However, in spite of the assumption made
in our model, where personnel requirements were aligned
to the capital resources, our data show that the relative
stafﬁng needs do not exactly track with the machine ca-
pacity. For example, although Africa is in need of more than
double their present staff, in linewith the departmental and
equipment needs, North America shows a need of an
additional 2% in its staff, regardless of the fact that it has
double the capacity in terms of available machines. This can
be explained by the projected technological upgrades,
differing between LMICs and HICs. As a consequence, North
America is still assumed to require an adjustment in stafﬁng
levels, especially for medical physicists.
This ﬁne-tuning of the needs to the assumed complexity
of the treatments, hence technological capability of theadiotherapy Needs and Costs by Geographic Region and Income Level,
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unique for the activity-based approach used in this model.
This methodology was ﬁrst adopted in the report of the
GTFRCC [2], yet all other previous publications estimating
the needs of radiotherapy capital and/or personnel re-
sources used more simple computations relying on an
average throughput of treatment courses per year, per linac
or per radiotherapy professional [5,6,10,12,30]. Seeing the
quickly evolving radiotherapy landscape, in terms of treat-
ment techniques as well as fractionation schedules, ap-
proaches such as the one presented, taking into account
these variables, may provide more accurate estimates.
The results of Table 1 and Figure 2 show regional aver-
ages. However, additional investment may be more
dependent on the income level of the speciﬁc country than
on the GNI group or the geographic region. This is clear in
Asia Paciﬁc: overall, this is the region with the highest ab-
solute investments needed, in line with its high population
density and the ensuing cancer incidence and additional
radiotherapy treatments indicated. Yet, in this geographic
region there are huge disparities in radiotherapy coverage,
varying from countries with no radiotherapy availability to
countries with optimal access, as shown in the GTFRCC
report [2]. As an example, one can look at the differences
between countries like Australia, India and Afghanistan,
with the former having adequate radiotherapy coverage
and the second between 40% and 60%, both assuming 12 h
of operation daily, whereas the latter had no radiotherapy at
the time of the report [2].
Ongoing Operating and Treatment Costs
Once the additional resources to generate new capacity
have been deﬁned, the ongoing operating costs need to be
maintained, both to treat patients and to maintain the
infrastructure. Although the Lancet Oncology report [2]
indicated that the percentile importance of capital and
human resources does vary by income regions e for HICs,
total operating costs were divided between equipment
(30%), facilities (6%) and salaries (64%), whereas in LICs
these were 81%, 9% and 10%, respectively e this has less of
an impact on the total additional operating costs, as calcu-
lated at present. Indeed, the additional operational costs in
all world regions align closely with the additional invest-
ment (Figure 3). As shown in Figure 3, in regions where
personnel costs on average are very low, especially in Africa
and to a lesser extent in Asia Paciﬁc, this translates into a
slightly lower incremental operational cost in comparison
with the investment. Thus, the challenges are not only to
generate the funding for capital and training costs, but also
to maintain operational capability. These challenges have a
somewhat different emphasis in different income settings.
The intra-regional disparities are further exempliﬁed
when comparing these results with the results of the
GTFRCC report [2]. From GTFRCC, the HIC operating cost per
fraction is US$235, whereas the similar result for North
America from this study is US$363 (Table 1, with cost per
course divided by 19.4 fractions). The reason for the large
difference is due to North America having a utilisation ratePlease cite this article in press as: Zubizarreta E, et al., Analysis of Global Ra
Clinical Oncology (2016), http://dx.doi.org/10.1016/j.clon.2016.11.011of 53% for linacs in a scenario of 12 working hours per day,
which increases the impact of maintenance and amor-
tisation costs in the annual operational costs. Africa being
largely an L-MIC region has a cost/fraction of US$67 in this
study compared with the US$60 and US$65 for LIC and L-
MIC in the GTFRCC report.
Turning to the actual cost per treatment course, there are
limited data to compare these results with previous reports.
Data for lower income settings are sparse, only cover the
treatment delivery component and are now out-dated [17].
There are some data available for Belgium, an HIC in Europe,
where the costs have been computed with a similar TD-ABC
approach at the departmental level. In a report of the
Belgian Health Care Knowledge Centre, where the treat-
ment costs of 10 operational departments were analysed in
2012, the average treatment cost amounted at V4209
(US$5472) [30]. In a single institution exercise, analysing
treatment costs after the introduction of intensity-
modulated radiotherapy, a similar cost of V3656
(US$4753) was calculated in 2009 [31]. Based on these
limited comparative data, using a similar calculation
method, the costs calculated in this report for the Europe
region seem to be valid.
Our data provide a picture of investment, operational
and radiotherapy costs per treatment in the various regions
of the world, using TD-ABC. Resource cost data calculated
with conventional cost-accounting models such TD-ABC are
to date scarce and are mostly focusing on costs at the
departmental level [16]. In view of the observed variation in
the average GNI/capita in the different countries consti-
tuting the income levels per world region, further cost an-
alyses at the country level would be welcomed to provide
more reﬁned insight and allow benchmarking among
countries.
The Bigger Picture
In HIC environments, the healthcare costs can be as
much as 8.4% (UK in 2007) to 18% (USA in 2009) of a
country’s gross domestic product [32]. Cancer consumes
about 5e10% of the global healthcare budget, of which
radiotherapy only consumes about 5% [32e34]; thus,
radiotherapy consumes about 0.5e1% of the total healthcare
budget. In the 28 member states of the European Union, the
average healthcare expenses of cancer were equivalent to
US$114 per citizen, but varied substantially from US$18 per
person in Bulgaria to US$205 per person in Luxembourg
[34]. Based on data obtained in our model, the cost per
capita related to radiotherapy in the 49 European countries
considered in this report, amounted to US$7.36 on average,
and more speciﬁcally to US$11.86 in HICs, US$2.02 in U-
MICs and US$1.25in L-MICs. Although this type of data has
not been reported for the other geographic regions in the
world, the consistency found for our European datawith the
data from Luengo-Fernandez et al. [34] allow us at least to
make some assumption regarding the other regions: the
average cost for radiotherapy spent per capita based on our
calculations was US$0.53 for Africa, US$1.70 for Asia Paciﬁc,
US$1.98 for Latin America and US$18.80 for North America.diotherapy Needs and Costs by Geographic Region and Income Level,
E. Zubizarreta et al. / Clinical Oncology xxx (2016) 1e98Certainly for HICs, the cost of radiotherapy is a very small
fraction of the total healthcare budget. Recognition of this
low cost is signiﬁcant considering that about 20e25% of the
population is expected to go through radiation treatment at
some point in their lives.Summary
Reviews of the cost of healthcare are often carried out
based on geographic regions of the world, such as Africa,
Asia Paciﬁc, Europe, Latin America and North America.
Furthermore, countries are often deﬁned by their income
levels based on World Bank deﬁnitions of HIC, U-MIC, L-
MIC, LIC.
This analysis has described the actual status and the
present needs and costs to provide full access to radio-
therapy globally, with a focus on the geographic regions.
Our data have shown that the costs e including investment
as well as operational costs and cost per treatment e vary
substantially by geographic region. These cost data are in
line with the treatment courses and associated resources
required to close the gap in radiotherapy coverage that
exists to date. Actual coverage of the needs ranges from 34%
in Africa to over 92% in Europe to about double the needs in
North America. In line with this, proportional additional
investments and operational costs are as high as more than
200% in Africa to almost none in North America.
Two world regions face a substantial challenge: Africa, as
in a vast proportion of the continent radiotherapy has
almost to be built up from scratch, with the related in-
vestments in human and capital resources and the subse-
quent challenge to maintain operational capability; and
Asia Paciﬁc, mainly due to the high population density,
translating into large absolute ﬁgures in terms of radio-
therapy indications, resources needed and associated costs.
As our data have highlighted it is clear that additional
investment in resources and costs may be more dependent
on the income level of the country than on GNI group or
geographic region of the world. This should be taken into
account for decision-making regarding expansion of
radiotherapy services in speciﬁc countries. Further analysis
on investment models and operational sustainability at the
country level is needed, which should go beyond the
availability of radiotherapy resources as such, yet should
also encompass analysis of service distribution models, of
enabling services supporting a global oncology programme
and of the contextual readiness in terms of general infra-
structure, ﬁnances and awareness at country level.
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